Mariner Wealth Advisors (NYC)’s Regeneron Pharmaceuticals REGN Stock Holding History

Mariner Wealth Advisors (NYC)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$2K	Buy	+5	New	+$2.12K	﹤0.01%	657

Other funds holding REGN

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Mariner Wealth Advisors (NYC)'s REGN Position: Q1 2015 in Review

Mariner Wealth Advisors (NYC) opened a new position in Regeneron Pharmaceuticals (REGN) in Q1 2015: 5 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #657 among its holdings.

509 funds tracked by Wall St. Rank hold REGN as of Q1 2015.

Mariner Wealth Advisors (NYC) held 5 shares of Regeneron Pharmaceuticals worth $2K as of Q1 2015.
Regeneron Pharmaceuticals was a new Mariner Wealth Advisors (NYC) position in Q1 2015.
Regeneron Pharmaceuticals made up ﹤0.01% of Mariner Wealth Advisors (NYC)'s portfolio in Q1 2015, its #657 holding.
509 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2015.

Based on Mariner Wealth Advisors (NYC)'s 13F filing for Q1 2015, filed 14 May 2015.